In Vitro Antibacterial Activity of Galla Chinensis Combined with Different Antibacterial Drugs against Carbapenem-Resistant E.Coli by Xie, Zhizhi et al.
19
Journal of Advances in Medicine Science | Volume 02 | Issue 04 | October 2019
Distributed under creative commons license 4.0 DOI: https://doi.org/10.30564/jams.v2i4.1229
Journal of Advances in Medicine Science
https://ojs.bilpublishing.com/index.php/jams
ARTICLE
In Vitro Antibacterial Activity of Galla Chinensis Combined with Dif-
ferent Antibacterial Drugs against Carbapenem-Resistant E.Coli  
Zhizhi Xie1 Changzhi Xu1 Yanhua Yi2 Donglin Zhu1 Yun Xi1*  
1. Department of Laboratory Medicine, The Third Af liated Hospital of Sun Yat-sen University, Guangzhou, Guang-
dong, 510630, China




Received: 19 September 2019
Revised: 26 September 2019
Accepted: 22 October 2019
Published Online: 31 October 2019  
Objective: To evaluate the antibacterial effects of meropenem and levo-
 oxacin respectively combined with Galla chinensis on carbapenem-resis-
tant Escherichia coli in vitro. Methods: The protocol was designed with 
checkerboard method and the carbapenem-resistant E.coli was isolated in 
our hospital. The minimum inhibitory concentrations(MICs) of G. chinen-
sis alone and combined with 2 antimicrobial agents against carbapenem-re-
sistant E.coli were determined by broth dilution method and the fractional 
inhibitory concentration index (FICI) was calculated according to MICs 
results. Result: the combined use of G. chinensis and meropenem (or levo-
 oxacin) signi cantly decreased both MIC50 and MIC90; After the com-
bination of G. chinensis and meropenem, the synergistic effect was 86.7%, 
and the additive effect was 13.3%, no irrelevant and antagonistic effects. 
After combined use of G. chinensis and levo oxacin, the synergistic effect 
was 66.7%, and the additive effect was 33.3%. No irrelevant and antago-
nistic effects. Conclusion: Galla chinensis combined with meropenem or 






Combination therapy  
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1. Introduction
E
scherichia coli (E. coli) is a common Gram-nega-
tive pathogen in the hospital and is widely found 
in nature. It is a normal flora in the human and 
animal gut[1]. E. coli can cause a variety of infections 
when the body’s immunity is reduced, the colony of the 
 ora changes, or the  ora is out of tune. According to the 
monitoring of bacterial resistance in China, E. coli is the 
highest-prevalence Gram-negative bacteria in the clinic, 
which can cause diarrhea, urinary tract infection, wound 
infection, bacteremia, meningitis and other diseases[2,3].
In recent years, with the increasing use of antibiotics, 
the detection rate of multidrug-resistant (MDR) E. coli in 
the clinic has increased year by year. It has posed a major 
challenge to clinical anti-infective treatment. In the face 
of this severe clinical anti-infective situation, carbapenem 
antibiotics are often used as clinically effective antibacte-
rial drugs for clinical treatment[4]. However, with the in-
crease in the clinical use of carbapenem antibiotics, more 
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and more clinical detection of carbapenem-resistant E. 
coli has brought great challenges to clinical anti-infective 
treatment. With the continuous development and deepen-
ing of the research work on anti-infection of traditional 
Chinese medicine by domestic medical workers, the re-
searchers found that some of the traditional Chinese med-
icines have effective antibacterial activity and can be used 
for antibacterial therapy or combined other antibacterial 
drugs for combined antibacterial therapy[5,6]. Studies have 
shown that G. chinensis in traditional Chinese medicine 
have good effective biological activities such as antibac-
terial, anti-caries, anti-mutation and anti-oxidation[6,7]. 
Therefore, this study will conduct a basic study on the an-
tibacterial activity in vitro of G. chinensiss combined with 
different antibacterial drugs against carbapenem-resistant 
E.coli, in order to provide a basis for  nding a reasonable 
and effective antibiotic treatment in the clinic.
2. Materials and Methods
2.1 Strain Specimens and Standard Strains
After removing duplicate strains isolated from the same 
site of the same patient, 30 strains of carbapenem-resis-
tant E.coli isolated from Lingnan Hospital of the Third 
Af liated Hospital of Sun Yat-sen University (June 2016 
to June 2017). Identification and drug susceptibility test 
of isolated strains was performed using a fully automatic 
bacterial identi cation analyzer (MicroScan WalkAway-96 
plus). 30 specimens of carbapenem-resistant E.coli were 
mainly derived from sputum, accounting for 50% (15/30), 
followed by blood 20% (6/30) and urine 10% (3/30), oth-
er specimens 20% (6/30). E.coli ATCC25922 and Pseu-
domonas aeruginosa ATCC27853 were used as quality 
control strains and provided by the Guangdong Center for 
Clinical Laboratory.
2.2 Instruments and Reagents
MicroScan Walk-Away 96 plus (Siemens, Germany), a 
fully automated bacterial identi cation and susceptibility 
analyzer (including supporting reagents and slats) was 
used. DR100 turbidimeter (Biomerieux, France); ul-
tra-clean workbench (Beijing Donglian Haar Instrument 
Manufacturing Company, China)); 96-well plate (Corning, 
USA); MH (Mueller-Hinton) broth, sterile Saline, mero-
penem and levo oxacin standard (Wenzhou Kangtai Bio-
logical Company, China); Galla (Guangdong side pharma-
ceutical company, China).
2.3 Preparation of Bacterial Suspension
After the culture on the blood plate for 18~24h, pick up 
3~5 pure colonies, use a sterile cotton swab to grind and 
mix in sterile physiological saline, and adjust the turbidity 
to 0.5 Mcfarland standard using DR100 type turbidimeter, 
and then use MH broth to dilute the turbidity-adjusted 
bacterial liquid by a factor of 100.
2.4 Preparation of Antibacterial Drugs
Weigh the appropriate amount of each drug with an ana-
lytical balance. G. chinensis was dissolved in ddH2O at a 
concentration of 10240 μg/mL. According to the require-
ments of the CLSI standard, the concentration of mero-
penem and levo oxacin was 5120 μg/mL.
2.5 The Micro Broth Dilution Method
Each antibacterial drug was diluted to 10 concentration 
gradients according to the dilution method by using MH 
broth sterilized in an autoclave. The concentration of G. 
chinensis was 10μg/ml~5120 μg/mL, the concentration of 
meropenem was 0.5μg/ml~2560μg/mL, and the concen-
tration of levofloxacin was 2.5μg/ml~1280μg/mL. First, 
add 100 μL of different concentrations of antibiotics to 
each of the 1st to 10th holes of each horizontal row of 
the sterile 96-well culture plate, and then add 100 μL of 
bacterial suspension to each well. In addition, the negative 
control and the blank control were simultaneously used 
as quality control during the test. The culture plate with 
the added bacterial solution was placed in an incubator at 
37°C for 16h to 20h. After the completion of the culture, 
the minimum inhibitory concentration (MIC) value of the 
different antibacterial drugs used alone was recorded (MI-
Calone). The test was repeated 3 times.
2.6 The Micro Broth Checkerboard Dilution 
Method
According to the checkerboard method, the antibacterial 
combination design was carried out. First, different exper-
imental antibacterial drugs were double diluted with MH 
broth to 8 different antimicrobial concentration gradients 
according to the 2 times MIC value of using the single 
drug. Take meropenem and levo oxacin respectively com-
bined with Galla chinensis, and then add 50 μL of each an-
tibiotic suspension to each well. Finally, add 100 μL of the 
diluted strain suspension, and incubate at 37 °C for 16 h to 
20 h. After observing the test results and recording the MIC 
value of each antibacterial drug in the best combination 
of antibacterial drugs, in addition, the fractional inhibitory 
concentration index (FICI) value was calculated.
2.7 Calculation and Judgment of FICI Value[8]
The FICI value is considered the standard reference pa-
DOI: https://doi.org/10.30564/jams.v2i4.1229
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rameter to quantify pairwise drug interactions in antimi-
crobial research. The FIC of drug A (FICA) is de ned as 
the MIC of drug A in the presence of drug B divided by 
the MIC of drug A alone (FICA = [MICA(B)/MICA]); 
and vice versa (FICB = [MICB(A)/MICB]). The sum of 
FICA plus FICB gives the FICI (FICI = FICA + FICB), an 
indication of the degree of drug interaction. When FICI ≤ 
0.5, it is synergistic. When 0.5 < FICI ≤ 1.0, it is additive. 
When 1.0 < FICI ≤ 2.0, it is irrelevant. When FICI > 2.0, 
it is antagonistic.
2.8 Statistical Analysis
Statistical analysis of the experimental data was per-
formed using SPSS 22.0 statistical software. The syner-
gistic rate between the two groups of antibiotics was com-
pared by χ2 test. p Value <0.05 was considered to indicate 
statistical signi cance.
3. Results
3.1 Comparison of MIC Values of Antibacteri-
al Drugs against Carbapenem-resistant E. coli 
When Used Alone or in Combination
The results showed that when G. chinensis was combined 
with meropenem, the MIC50(the MIC required for 50% 
of the bacteria to be inhibited) and the MIC90 (the MIC 
required for 90% of the bacteria to be inhibited) of the two 
antibacterial drugs were signi cant declined. The MIC50 
and MIC90 of G. chinensis were 1/4 of that when the drug 
was used alone, and the MIC50 and MIC90 of meropen-
em were 1/32 and 1/4 of that of the drug was used alone; 
When G. chinensis was combined with levo oxacin, the 
MIC50 and MIC90 of G. chinensis were 1/4 of that when 
the drug was used alone, and the MIC50 and MIC90 of 
levofloxacin were 1/8 and 1/64 of that of the drug was 
used alone, as shown in Table 1.
Table 1. MIC values of G. chinensis with meropenem and 
levo oxacin alone or in combination against carbapen-






MIC50 MIC90 range MIC50 MIC90 range
G. chinen-
sis
640 2560 80~5120 160 640 40~640
Meropen-
em
640 1280 20~2560 20 320 5~320
G. chinen-
sis
640 2560 80~5120 160 640 40~1280
Levo ox-
acin
40 640 10~1280 5 10 1.25~10
3.2 The FICI Distribution of G. chinensis against 
Carbapenem-resistant E. coli When Combined 
with Meropenem or Levo oxacin
When G. chinensis was combined with meropenem, the 
synergistic effect was 86.7%, the additive effect was 
13.3%, and the irrelevance and antagonism were 0; When 
G. chinensis was used in combination with levo oxacin, 
the synergistic effect was 66.7%, the additive effect was 
33.3%, and the irrelevance and antagonism also were 
0,as shown in Table 2. The synergistic ratio (synergistic 
effect+additive effect) of the two different antimicrobial 
combinations was indicated no statistical signi cance. (P
> 0.05).
Table 2. The FICI distribution of G. chinensis against thir-
ty strains of carbapenem-resistant E. coli when combined 
with meropenem or levo oxacin
Drug combination FICI ≤ 0.5
0.5 < FICI ≤ 
1.0






26(86.7%) 4(13.3%) 0(0%) 0(0%)
G. chinensis+Levo-
 oxacin
20(66.7%) 10(33.3%) 0(0%) 0(0%)
4. Discussion
Galla chinensis, a nontoxic Chinese herbal medicine, is 
naturally formed when Rhus chinensis Mill is parasitized 
by Melaphis chinensis Bell. G. chinensis is considered to 
be a potential antibacterial agent. The main active ingredi-
ent of G. chinensis is G. chinensis tannin, which is formed 
by the condensation of 7 to 9 molecules of gallic acid and 
1 molecule of glucose. The content is about 60% to 70%, 
even up to 80%; G. chinensis tannin can be made into 
nearly 100 kinds of  ne chemical products by puri cation 
and synthesis. It has been widely used in medicine, chem-
ical industry and food, and has become a research hotspot 
in the research  eld[7]. G. chinensis not only has the effect 
of clearing away heat and detoxification, but also has 
a significant broad-spectrum antibacterial effect. In the 
early studies, the MIC rsults of G. chinensis ethanol ex-
tract against 140 strains of Enterococcus showed that the 
MIC90 of G. Chinensi against Enterococcus. faecalis, En-
terococcus faecium and other Enterococcus was 0.315mg/
mL, 0.63mg/mL and 0.63 mg/mL, respectively, which 
suggesting that G. chinensis ethanol extract has strong an-
tibacterial activity against Enterococcus[9]. Li Kaixuan et 
al. also found that G. chinensis has effective antibacterial 
activity by detecting the antibacterial activity of Chinese 
herbal extracts against multi-drug resistant Acinetobacter 
baumannii[6]. In this study, the bacteriostatic activity of G. 
chinensis against carbapenem-resistant E.coli was tested 
DOI: https://doi.org/10.30564/jams.v2i4.1229
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to show that the MIC value of 80~5120μg/mL has certain 
effective antibacterial activity.
In recent years, the detection rate of carbapenem-resis-
tant E.coli in the clinic has gradually increased, which has 
brought great challenges to clinicians’ anti-infective treat-
ment. Faced with the increasingly severe drug resistance 
situation and the slow development of new effective anti-
bacterial drugs, it is of great signi cance to carry out the 
deep excavation of traditional Chinese medicines and the 
combination of antibacterial drugs for anti-infective treat-
ments[10,11]. Both meropenem and levofloxacin are com-
monly used antibacterial drugs in the clinic and as drug 
use increases, there is more drug resistance. Therefore, 
finding synergistic antibacterial drugs for anti-infective 
treatment plays an important role in the rational and effec-
tive use of clinical antibacterial drugs. In this study, the 
results indicated that G. chinensis has a certain combined 
effect when used in combination with meropenem or levo-
 oxacin. When G. chinensis was combined with meropen-
em, the MIC50 and MIC90 of the two antibacterial drugs 
were significant declined. The MIC50 and MIC90 of G. 
chinensis were 1/4 of that when the drug was used alone, 
and the MIC50 and MIC90 of meropenem were 1/32 and 
1/4 of that of the drug was used alone; When G. chinensis 
was combined with levo oxacin, the MIC50 and MIC90 
of G. chinensis were 1/4 of that when the drug was used 
alone, and the MIC50 and MIC90 of levofloxacin were 
1/8 and 1/64 of that of the drug was used alone. In addi-
tion, when G. chinensis was combined with meropenem, 
the synergistic effect was 86.7%, the additive effect was 
13.3%, and the irrelevance and antagonism were 0; When 
G. chinensis was used in combination with levo oxacin, 
the synergistic effect was 66.7%, the additive effect was 
33.3%, and the irrelevance and antagonism also were 0. 
These also indicated that the combination of G. chinensis 
and the above two antibacterial drugs has a certain com-
bined effect. The results are different from those reported 
by Zhang Haiyue et al.[12] and Wang Lingjing[13], which 
may be related to the difference of strains.[14] In this study, 
the clinically isolated carbapenem-resistant E. coli were 
selected. Zhang Haiyue et al. used bovine levo oxacin-re-
sistant E. coli, and Wang Lingjing et al. chosed multi-
drug resistant Pseudomonas aeruginosa. The mechanism 
of bacterial resistance is complex, and it can be resistant 
to antibiotics by producing β-lactamase, change in cell 
membrane permeability, active efflux pumps, change in 
drug targets, and biofilm formation[15]. Wang Lingjing 
et al. showed that G. chinensis alone or in combination 
with cipro oxacin can promote the expression of multiple 
drug-resistant Pseudomonas aeruginosa (MDR-PA) ef ux 
pump genes to different extents, suggesting that Chinese 
medicine passes promote ef ux pump gene expression to 
play an antagonistic role in antibiotics. It is suggested that 
there may be different types of bacteria, and the mecha-
nism of resistance is also different, resulting in differences 
in experimental results[16,17].
5. Conclusion
In summary, this study found that G. chinensis combined 
with meropenem or levo oxacin has a certain combined 
antibacterial effect on anti-infective treatment of carbape-
nem-resistant E.coli, and this treatment can be considered 
for anti-infective treatment in clinical practice. However, 
this study also has defects such as the small number of re-
search strains and the small number of antibacterial drugs, 
and we will further study them in future research.
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